COVID-19 Vaccine Update: Novavax starts phase I/II clinical trials, here’s all you need to know about the vaccine
Named NVX‑CoV2373, Novavax’s vaccine is created using recombinant protein nanoparticle technology.
The post COVID-19 Vaccine Update: Novavax starts phase I/II clinical trials, here’s all you need to know about the vaccine appeared first on Firstpost.
Comments
Post a Comment